Repligen Corp. (RGEN)
181.70
+4.47
(+2.52%)
USD |
NASDAQ |
Oct 02, 16:00
181.62
-0.08
(-0.04%)
Pre-Market: 20:00
Repligen Price to Book Value : 4.854 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 4.854 |
| October 01, 2026 | 4.735 |
| September 30, 2026 | 5.136 |
| September 29, 2026 | 5.198 |
| September 28, 2026 | 5.186 |
| September 25, 2026 | 5.068 |
| September 24, 2026 | 5.094 |
| September 23, 2026 | 4.930 |
| September 22, 2026 | 4.989 |
| September 21, 2026 | 4.828 |
| September 18, 2026 | 4.726 |
| September 17, 2026 | 4.761 |
| September 16, 2026 | 4.620 |
| September 15, 2026 | 4.668 |
| September 14, 2026 | 4.488 |
| September 11, 2026 | 4.413 |
| September 10, 2026 | 4.400 |
| September 09, 2026 | 4.410 |
| September 08, 2026 | 4.503 |
| September 04, 2026 | 4.478 |
| September 03, 2026 | 4.532 |
| September 02, 2026 | 4.620 |
| September 01, 2026 | 4.542 |
| August 31, 2026 | 4.835 |
| August 28, 2026 | 4.709 |
| Date | Value |
|---|---|
| August 27, 2026 | 4.863 |
| August 26, 2026 | 4.817 |
| August 25, 2026 | 4.854 |
| August 24, 2026 | 4.852 |
| August 21, 2026 | 4.839 |
| August 20, 2026 | 4.817 |
| August 19, 2026 | 4.712 |
| August 18, 2026 | 4.439 |
| August 17, 2026 | 4.516 |
| August 14, 2026 | 4.457 |
| August 13, 2026 | 4.475 |
| August 12, 2026 | 4.427 |
| August 11, 2026 | 4.402 |
| August 10, 2026 | 4.359 |
| August 07, 2026 | 4.379 |
| August 06, 2026 | 4.260 |
| August 05, 2026 | 4.237 |
| August 04, 2026 | 4.002 |
| August 03, 2026 | 3.929 |
| July 31, 2026 | 3.767 |
| July 30, 2026 | 3.837 |
| July 29, 2026 | 3.773 |
| July 28, 2026 | 3.883 |
| July 27, 2026 | 3.502 |
| July 24, 2026 | 3.526 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLife Solutions, Inc. | 4.342 |
| Precigen, Inc. | 70.16 |
| Liquidia Corp. | 13.08 |
| Harmony Biosciences Holdings, Inc. | 2.306 |
| Bio-Techne Corp. | 5.361 |
Price to Book Value Related Metrics
| PE Ratio | 247.65 |
| PS Ratio | 13.10 |
| Price to Free Cash Flow | 93.40 |
| Price | 181.70 |
| Earnings Yield | 0.40% |
| Market Cap | 10.25B |
| Operating PE Ratio | 145.06 |
| Normalized PE Ratio | 222.62 |